Report Detail

Other Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Insights, Forecast to 2025

  • RnM3536234
  • |
  • 17 June, 2019
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Other

Percutaneous transluminal coronary angioplasty (PTCA) is a minimally invasive procedure to open up blocked coronary arteries, allowing blood to circulate unobstructed to the heart muscle.
The global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market based on company, product type, end user and key regions.

This report studies the global market size of Percutaneous Transluminal Coronary Angioplasty (PTCA) Products in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Percutaneous Transluminal Coronary Angioplasty (PTCA) Products in these regions.
This research report categorizes the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market by top players/brands, region, type and end user. This report also studies the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbott Laboratories
Terumo
Boston Scientific
Intact Vascular
Asahi Intecc
Angioscore
Bard PV
Cook Medical
Cordis
Medtronic
Biosensors International

Market size by Product
PTCA ballon
PTCA guide
Market size by End User
OEMS
Aftermarket

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Percutaneous Transluminal Coronary Angioplasty (PTCA) Products submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Percutaneous Transluminal Coronary Angioplasty (PTCA) Products are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size Growth Rate by Product
      • 1.4.2 PTCA ballon
      • 1.4.3 PTCA guide
    • 1.5 Market by End User
      • 1.5.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size Growth Rate by End User
      • 1.5.2 OEMS
      • 1.5.3 Aftermarket
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size
      • 2.1.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue 2014-2025
      • 2.1.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales 2014-2025
    • 2.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Growth Rate by Regions
      • 2.2.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales by Regions
      • 2.2.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales by Manufacturers
      • 3.1.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales by Manufacturers
      • 3.1.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales Market Share by Manufacturers
      • 3.1.3 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Concentration Ratio (CR5 and HHI)
    • 3.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue by Manufacturers
      • 3.2.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue by Manufacturers (2014-2019)
      • 3.2.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue Share by Manufacturers (2014-2019)
    • 3.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Price by Manufacturers
    • 3.4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Manufacturing Base Distribution, Product Types
      • 3.4.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Product Type
      • 3.4.3 Date of International Manufacturers Enter into Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales by Product
    • 4.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue by Product
    • 4.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Breakdown Data by End User

    6 North America

    • 6.1 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Countries
      • 6.1.1 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales by Countries
      • 6.1.2 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product
    • 6.3 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by End User

    7 Europe

    • 7.1 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Countries
      • 7.1.1 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales by Countries
      • 7.1.2 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product
    • 7.3 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Countries
      • 8.1.1 Asia Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales by Countries
      • 8.1.2 Asia Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product
    • 8.3 Asia Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by End User

    9 Central & South America

    • 9.1 Central & South America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Countries
      • 9.1.1 Central & South America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales by Countries
      • 9.1.2 Central & South America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product
    • 9.3 Central & South America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Countries
      • 10.1.1 Middle East and Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales by Countries
      • 10.1.2 Middle East and Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product
    • 10.3 Middle East and Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by End User

    11 Company Profiles

    • 11.1 Abbott Laboratories
      • 11.1.1 Abbott Laboratories Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Abbott Laboratories Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Abbott Laboratories Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Products Offered
      • 11.1.5 Abbott Laboratories Recent Development
    • 11.2 Terumo
      • 11.2.1 Terumo Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Terumo Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Terumo Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Products Offered
      • 11.2.5 Terumo Recent Development
    • 11.3 Boston Scientific
      • 11.3.1 Boston Scientific Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Boston Scientific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Boston Scientific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Products Offered
      • 11.3.5 Boston Scientific Recent Development
    • 11.4 Intact Vascular
      • 11.4.1 Intact Vascular Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Intact Vascular Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Intact Vascular Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Products Offered
      • 11.4.5 Intact Vascular Recent Development
    • 11.5 Asahi Intecc
      • 11.5.1 Asahi Intecc Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Asahi Intecc Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Asahi Intecc Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Products Offered
      • 11.5.5 Asahi Intecc Recent Development
    • 11.6 Angioscore
      • 11.6.1 Angioscore Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Angioscore Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Angioscore Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Products Offered
      • 11.6.5 Angioscore Recent Development
    • 11.7 Bard PV
      • 11.7.1 Bard PV Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Bard PV Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Bard PV Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Products Offered
      • 11.7.5 Bard PV Recent Development
    • 11.8 Cook Medical
      • 11.8.1 Cook Medical Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Cook Medical Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Cook Medical Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Products Offered
      • 11.8.5 Cook Medical Recent Development
    • 11.9 Cordis
      • 11.9.1 Cordis Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Cordis Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Cordis Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Products Offered
      • 11.9.5 Cordis Recent Development
    • 11.10 Medtronic
      • 11.10.1 Medtronic Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Medtronic Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Medtronic Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Products Offered
      • 11.10.5 Medtronic Recent Development
    • 11.11 Biosensors International

    12 Future Forecast

    • 12.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Forecast by Regions
      • 12.1.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue Forecast by Regions 2019-2025
    • 12.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Forecast by Product
      • 12.2.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Sales Forecast by Product 2019-2025
      • 12.2.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue Forecast by Product 2019-2025
    • 12.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Forecast by End User
    • 12.4 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecast
    • 12.5 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecast
    • 12.6 Asia Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecast
    • 12.7 Central & South America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecast
    • 12.8 Middle East and Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Percutaneous Transluminal Coronary Angioplasty (PTCA) Products . Industry analysis & Market Report on Percutaneous Transluminal Coronary Angioplasty (PTCA) Products is a syndicated market report, published as Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,900.00
      $7,350.00
      $9,800.00
      3,679.90
      5,519.85
      7,359.80
      4,390.40
      6,585.60
      8,780.80
      705,306.00
      1,057,959.00
      1,410,612.00
      409,493.00
      614,239.50
      818,986.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report